AstraZeneca, AZN
Hosted on MSN19h
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLCAstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...
AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...
Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...
LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
Lunit announced a strategic collaboration with AstraZeneca (AZN) to develop AI-powered digital pathology solutions. The solution in focus is Lunit SCOPE Genotype Predictor, an AI-powered tool ...
This combination drug is used to treat chronic obstructive pulmonary disease in adults, relieving symptoms and preventing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback